RMC-5552

· Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RMC-5552, covering 2025-04-15 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma [Phase 1]